COLLEGIUM PHARMACEUTICAL, INC Quarterly Interest Expense in USD from Q2 2015 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Collegium Pharmaceutical, Inc quarterly/annual Interest Expense history and growth rate from Q2 2015 to Q1 2024.
  • Collegium Pharmaceutical, Inc Interest Expense for the quarter ending March 31, 2024 was $17.3M, a 19.1% decline year-over-year.
  • Collegium Pharmaceutical, Inc Interest Expense for the twelve months ending March 31, 2024 was $79.3M, a 0.56% increase year-over-year.
  • Collegium Pharmaceutical, Inc annual Interest Expense for 2023 was $83.3M, a 31.8% increase from 2022.
  • Collegium Pharmaceutical, Inc annual Interest Expense for 2022 was $63.2M, a 201% increase from 2021.
  • Collegium Pharmaceutical, Inc annual Interest Expense for 2021 was $21M, a 27.2% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $79.3M $17.3M -$4.09M -19.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $83.3M $19.3M -$1.29M -6.29% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 $84.6M $20.8M +$1.72M +9.04% Jul 1, 2023 Sep 30, 2023 10-K 2024-02-22
Q2 2023 $82.9M $21.9M +$4.1M +23.1% Apr 1, 2023 Jun 30, 2023 10-K 2024-02-22
Q1 2023 $78.8M $21.4M +$15.6M +267% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $63.2M $20.6M +$15.8M +333% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 $47.4M $19M +$13.9M +272% Jul 1, 2022 Sep 30, 2022 10-K 2024-02-22
Q2 2022 $33.5M $17.8M +$12.3M +228% Apr 1, 2022 Jun 30, 2022 10-K 2024-02-22
Q1 2022 $21.1M $5.83M +$110K +1.92% Jan 1, 2022 Mar 31, 2022 10-K 2024-02-22
Q4 2021 $21M $4.76M -$2.98M -38.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-23
Q3 2021 $24M $5.12M -$2.95M -36.6% Jul 1, 2021 Sep 30, 2021 10-K 2023-02-23
Q2 2021 $26.9M $5.42M -$2.84M -34.4% Apr 1, 2021 Jun 30, 2021 10-K 2023-02-23
Q1 2021 $29.8M $5.72M +$898K +18.6% Jan 1, 2021 Mar 31, 2021 10-K 2023-02-23
Q4 2020 $28.9M $7.74M +$7.53M +3567% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-24
Q3 2020 $21.4M $8.06M +$7.84M +3436% Jul 1, 2020 Sep 30, 2020 10-K 2022-02-24
Q2 2020 $13.5M $8.26M +$8.02M +3400% Apr 1, 2020 Jun 30, 2020 10-K 2022-02-24
Q1 2020 $5.5M $4.82M +$4.59M +1961% Jan 1, 2020 Mar 31, 2020 10-K 2022-02-24
Q4 2019 $909K $211K -$2.19M -91.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 $3.1M $228K -$5.64M -96.1% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-25
Q2 2019 $8.74M $236K -$5.92M -96.2% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-25
Q1 2019 $14.7M $234K -$5.47M -95.9% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-25
Q4 2018 $20.1M $2.4M Oct 1, 2018 Dec 31, 2018 10-K 2020-02-27
Q3 2018 $5.87M Jul 1, 2018 Sep 30, 2018 10-K 2020-02-27
Q2 2018 $6.16M Apr 1, 2018 Jun 30, 2018 10-K 2020-02-27
Q1 2018 $5.7M Jan 1, 2018 Mar 31, 2018 10-K 2020-02-27
Q3 2016 $2K* -$95K Jul 1, 2016 Sep 30, 2016 10-Q 2016-11-10
Q2 2016 $46K -$53K -53.5% Apr 1, 2016 Jun 30, 2016 10-Q 2016-08-11
Q3 2015 $97K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 $99K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.